Side by side
Cardiogen vs Tesamorelin
Both are discussed for anti-aging & longevity. What this site records about each, side by side. Every figure is on the compound's own page with the source it came from.
| Cardiogen | Tesamorelin | |
|---|---|---|
| What it is | Assigned to cardiac tissue by the St Petersburg programme that invented this category. Four decades of Russian work sit behind it, and none of it has been reproduced anywhere else. | A GHRH analogue approved by the FDA for reducing excess visceral fat in HIV-associated lipodystrophy. The only compound in this category with completed phase 3 trials. |
| EvidenceHow much human evidence exists, not how well it works. | Preclinical | Approved for another indication |
| Regulatory statusReviewed 2026-08-18 | Not approved for human use in the United States, the European Union or the United Kingdom. Some peptides in this family are registered in Russia as supplements or medicines. Cardiogen is sold elsewhere as a research chemical. | Approved by the FDA as a prescription medicine for reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy. It is not approved for body composition, athletic performance or anti-ageing use, and material sold as a research chemical is not the approved product. |
| Routes | Subcutaneous, Oral | Subcutaneous |
| Half-life | Not recorded | 0.4 hours |
| Cheapest per mgVials only, read from vendors' own listings and dated on the price index. | $1.79/mg | $2.35/mg |
| Median per mg | $3.00/mg | $6.50/mg |
| Vendors with a price | 12 | 49 |
| Storage once mixed | Refrigerated at 2–8 °C. Do not freeze once mixed. | Refrigerated at 2–8 °C. The approved product is intended for use shortly after reconstitution rather than stored for weeks. |
Compare two other compounds · The full price index
This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on BioAlmanac is medical advice. Nothing here ranks these two against each other. A table can show that one has more human evidence behind it or costs less per milligram; neither of those is a recommendation, and the right comparison for any person is one their doctor makes with them.